Where do CDMOs and CROs have leverage to negotiate sponsor MSA insurance terms?

A small set of sponsor MSA insurance terms are essentially universal across the life-sciences contract manufacturing industry: (1) CGL with $1M/$2M limits and occurrence form, (2) Products and Completed Operations at the sponsor's required limit (typically $5M-$10M), (3) Workers Compensation per state law plus Employers Liability, (4) Additional insured for both ongoing operations AND products/completed ops, (5) Primary and non-contributory wording, (6) Waiver of subrogation, (7) A.M. Best A- VII or better carrier rating.

Operators that attempt to negotiate any of these terms encounter near-uniform sponsor pushback. The terms have become industry baseline.

Several terms are routinely negotiable: (1) products limits above $5M (sponsors will sometimes accept $5M instead of $10M for lower-risk product classes), (2) survival period length (10-year survival can sometimes be negotiated to 5-7 years), (3) indemnity caps aligned to insurance limits (vs uncapped indemnity), (4) mutual indemnity for sponsor-caused losses (vs one-way), (5) specific carveouts in indemnity for gross negligence and willful misconduct on both sides.

These negotiations are easier when the operator has clean claims history, established sponsor relationships, and a compliance-track-record story to tell.

A third tier of terms is negotiable when the operator has clear leverage: (1) elimination of "additional insured to subsidiaries and affiliates" expansive wording, (2) negotiation of specific carrier rating thresholds when the operator's incumbent carrier is rated B++ or below but otherwise well-positioned, (3) modification of cancellation notice provisions from 30 days to 15 or 10 days where the operator's carrier cannot provide 30, (4) acceptance of claims-made for D&O, professional liability, cyber where sponsor's default wording reads "occurrence form for all coverage" without intentional restriction.

These succeed when the operator can articulate why the sponsor's wording over-reaches and propose alternative language that still satisfies the sponsor's underlying intent.

Effective MSA insurance negotiation depends on three things: (1) understanding which terms are universal vs negotiable (covered above), (2) framing requested changes in terms of the sponsor's actual risk (not the operator's preference), (3) proposing alternative language rather than just objecting.

Example: rather than asking the sponsor to "remove the products/completed ops AI requirement," ask the sponsor to "accept a manuscripted blanket AI-for-products endorsement that covers all sponsors of record rather than a per-sponsor endorsement, which simplifies our administration without reducing your coverage." Same coverage; better operational fit.

Some MSA insurance terms reflect sponsor risk-aversion that translates to uneconomic operator commitments — uncapped indemnity coupled with $25M+ insurance requirements, 15-year survival, AI extending to sponsor affiliates worldwide. Operators should be willing to walk from MSAs where the insurance commitment is uneconomic, especially for first-time sponsor engagements.

The economics of saying no to a marginal sponsor relationship are typically better than the economics of saying yes to an MSA the operator cannot reasonably support.